Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

BISMUTH THERAPY EXCLUSIVELY IN CONGENITAL SYPHILIS

BISMUTH THERAPY EXCLUSIVELY IN CONGENITAL SYPHILIS Congenital syphilis has always been refractory to treatment. The fact of its resistance creates a situation by which, when compared to acquired syphilis, its prognosis is relatively unfavorable. As a result, adverse criticism is often directed against the use of drugs in the treatment of patients with congenital syphilis. Both comparison and criticism are obviously unfair, since it is recognized that in acquired syphilis the earlier the treatment the greater possibility of cure. It is fallacy, therefore, to expect the same favorable results when dealing with congenital syphilis, which is invariably of long duration, the new-born infant not excepted, since the disease has been present for months in utero. To compare the relative value of drugs used in both forms of syphilis, it should be determined whether the disease has been present in each type for the same length of time. If this is done, the dismal outlook so frequent http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American journal of diseases of children American Medical Association

BISMUTH THERAPY EXCLUSIVELY IN CONGENITAL SYPHILIS

Loading next page...
 
/lp/american-medical-association/bismuth-therapy-exclusively-in-congenital-syphilis-VL4EOBnXNz
Publisher
American Medical Association
Copyright
Copyright © 1930 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0096-8994
eISSN
1538-3628
DOI
10.1001/archpedi.1930.01930140050006
Publisher site
See Article on Publisher Site

Abstract

Congenital syphilis has always been refractory to treatment. The fact of its resistance creates a situation by which, when compared to acquired syphilis, its prognosis is relatively unfavorable. As a result, adverse criticism is often directed against the use of drugs in the treatment of patients with congenital syphilis. Both comparison and criticism are obviously unfair, since it is recognized that in acquired syphilis the earlier the treatment the greater possibility of cure. It is fallacy, therefore, to expect the same favorable results when dealing with congenital syphilis, which is invariably of long duration, the new-born infant not excepted, since the disease has been present for months in utero. To compare the relative value of drugs used in both forms of syphilis, it should be determined whether the disease has been present in each type for the same length of time. If this is done, the dismal outlook so frequent

Journal

American journal of diseases of childrenAmerican Medical Association

Published: Feb 1, 1930

There are no references for this article.